Pacific Biosciences
PACB
#3878
Rank
$1.69 B
Marketcap
$7.56
Share price
13.51%
Change (1 day)
-77.16%
Change (1 year)

Revenue for Pacific Biosciences (PACB)

Revenue in 2022 (TTM): $0.13 B

According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM) is $0.13 B. In 2021 the company made a revenue of $0.13 B an increase over the years 2020 revenue that were of $0.07 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacific Biosciences from 2010 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$0.13 B6.92%
2021$0.13 B65.43%
2020$0.07 B-13.2%
2019$0.09 B15.6%
2018$0.07 B-15.88%
2017$0.09 B3.04%
2016$0.09 B-2.23%
2015$0.09 B53.12%
2014$0.06 B115.02%
2013$0.02 B8.46%
2012$0.02 B-23.27%
2011$0.03 B1922.88%
2010$1.67 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$42.82 B 30,585.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$74.48 B 53,275.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.65 B 3,236.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.02 B 3,497.39%๐Ÿ‡บ๐Ÿ‡ธ USA
N/A-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.14 B 3.58%๐Ÿ‡บ๐Ÿ‡ธ USA